You are here: Industry Insights > cambrex

News List

Permira Funds to Acquire Cambrex in $2.4B Transaction contractpharma
August 08, 2019
To back Cambrex in its next phase of growth.
Cambrex Expands Process Development at Edinburgh Facility contractpharma
July 31, 2019
Doubles current footprint to 15,000 sq. ft., adding lab space to accommodate 40 more scientists.
Cambrex Makes Senior Appointments contractpharma
July 01, 2019
New roles to further support the company’s CDMO business.
Cambrex Completes New Process and Analytical Development Facility contractpharma
June 05, 2019
Located at its Karlskoga, Sweden manufacturing site.
Cambrex Completes Highly Potent API Mfg. Site contractpharma
April 15, 2019
Investment in Charles City, IA site totaled $24 million.
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network pharmafocusasia
November 28, 2018
Cambrex Corporation, a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced......
Acquisition boosts Cambrex's early-stage development capabilities cphi-online
November 27, 2018
Avista is a portfolio company of Ampersand Capital Partners, a leading healthcare-focused private equity firm. With this acquisition, Cambrex will enter the large and growing market
Cambrex adds Avista Pharma to the fold in $250M deal fiercepharma
November 26, 2018
CDMO Cambrex likes its deals big or small. In September it closed the $425 million deal acquisition of Halo Pharma. This week it is buying a four-facility competitor in a $250 million deal.
Cambrex to create process development and clinical supply center of excellence cphi-online
November 15, 2018
Cambrex is to establish a center of excellence for API clinical supply and process development at its site in High Point, North Carolina. Cambrex will acquire its currently...
Cambrex enters growing finished dosage form market cphi-online
July 26, 2018
Acquisition of Halo Pharma adds competencies including developing and manufacturing products for pediatric indications.

Previous page 1 2 Next page